Patients inject the medication into fatty tissue, typically in the abdomen, thigh, or upper arm
There are, at present, several once weekly GLP-1 receptor agonists available in the market: exenatide long-acting release (LAR), albiglutide, dulaglutide and semaglutide.74,75 Head-to-head clinical trials data suggest that long-acting GLP-1 receptor agonists produce superior glycemic control when compared with their shortacting counterparts (exenatide and liraglutide)
During physical activity, elevated IL-6 levels can slow gastric motility, contributing to enhanced postprandial satiety and improved glycemic control
Support weight loss and metabolism*
A Gluten is found in foods such as breads and baked goods
Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study